Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

When do we treat hypercholesterolemia?

W V Brown1

  • 1Department of Medicine, Emory University, Atlanta, Georgia 30322.

Clinical Cardiology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Clinicians face challenges in treating high cholesterol despite established guidelines. Understanding individual patient factors is crucial for effective coronary heart disease prevention and treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective herbivory by Christmas beetles in response to intraspecific variation in Eucalyptus terpenoids.

Oecologia·2017
Same author

Dihydromatricariate-based triglycerides, glyceride ethers, and waxes in the australian soldier beetle,Chauliognathus lugubris (Coleoptera: Cantharidae).

Journal of chemical ecology·2013
Same author

Novel internally branched, internal alkenes as major components of the cuticular hydrocarbons of the primitive australian antNothomyrmecia macrops Clark (Hymenoptera: Formicidae).

Journal of chemical ecology·2013
Same author

Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

Landmark trials in lipid reduction.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same author

Cardiovascular disease and lipoproteins: available evidence and remaining questions. Reactor panel and open forum.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same journal

In-Hospital Cardiac Arrest Detection Performance Analysis and Comparison on Effective Feature Selection.

Clinical cardiology·2026
Same journal

Interpreting the Association Between Diuretic Intensity Score and Mortality: The Potential Roles of Diuretic Responsiveness and Mineralocorticoid Receptor Antagonist Therapy.

Clinical cardiology·2026
Same journal

Heart Failure With Preserved Ejection Fraction-Like Phenotype in Coronary Artery Disease and Obstructive Sleep Apnea: Insights From the RICCADSA Cohort.

Clinical cardiology·2026
Same journal

Ethanol Infusion Into the Vein of Marshall for Atrial Fibrillation: Clinical Efficacy and Technical Limitations.

Clinical cardiology·2026
Same journal

Methodological Considerations Regarding Diuretic Intensity Score and Mortality in Hospitalized Heart Failure Patients.

Clinical cardiology·2026
Same journal

Inpatient Outcomes and Complications After Left Atrial Appendage Occlusion in Rural Versus Urban Hospitals in the United States.

Clinical cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Established links between high total and low-density lipoprotein (LDL) cholesterol and coronary heart disease (CHD).
  • Availability of published treatment guidelines for hypercholesterolemia.

Observation:

  • Clinicians encounter complex issues in determining patient treatment.
  • Specific patient characteristics and risk factors influencing treatment decisions are less understood.

Findings:

  • Review of current hypercholesterolemia treatment guidelines.
  • Identification of therapeutic issues in patient selection.

Implications:

  • Need for further research into patient-specific factors for personalized treatment.
  • Enhanced clinical decision-making for hypercholesterolemia management.

Related Experiment Videos

  • Potential for improved coronary heart disease risk reduction through tailored therapies.